Hydrogenology
Hydrogenology editorial study record

Molecular Hydrogen Inhibits Colorectal Cancer Growth via the AKT/SCD1 Signaling Pathway

Zhang X et al. · Biomed Res Int. 2022;2022:8024452.

PreclinicalInhaled H₂Published 2022
Study record, not medical adviceThis page reports one source and Hydrogenology’s source-text extraction. It does not establish that molecular hydrogen is effective, safe or appropriate for any person. Human, animal and laboratory evidence must not be treated as equivalent.
Source and classification

What kind of evidence is this?

Evidence stream

Preclinical

Reported design

Colorectal-cancer cell experiments and randomized mouse xenograft experiment

Research topic

Cancer research

Administration classification

Inhaled H₂

Study result signal

Not reported in this record.

Outcome type

Not reported in this record.

Reported in the source

Methods at a glance

Population or model

RKO, SW480 and HCT116 colorectal-cancer cell lines; BALB/c nude mice bearing RKO xenografts

Sample

10 xenograft mice randomized to gas groups; cell experiments were repeated at least three times

Duration

2 hours/day for three weeks; tumors excised on day 21

Intervention

Mice inhaled a 66% H₂ and 33% O₂ mixture for 2 hours/day from day 2 through day 21

Hydrogen form

Brown’s gas / oxyhydrogen — H₂ and O₂ co-delivered from a hydrogen-oxygen generator.

H₂ specification

Source methods report 66% H₂ and 33% O₂; the chamber atmosphere was monitored by gas chromatography.

H₂ flow

Not reported — the article gives chamber concentration but no H₂ flow in mL/min.

O₂ delivered with H₂

33% O₂ was co-delivered; O₂ flow in mL/min was not reported.

Comparator

66% N₂ and 33% O₂ chamber exposure

Reported, not endorsed

Outcomes and reported result

Outcomes measured

Cell proliferation and apoptosis, xenograft tumor volume and weight, and AKT/SCD1 pathway measurements

Reported result

Tumor weight was 1.11 vs 1.56 g (p=0.021) and volume 898 vs 1413 mm³ (p=0.032) with oxyhydrogen versus control. Cell proliferation and pathway signals also changed; the 491 human tissue specimens were correlative and were not exposed to H₂.

Results-extraction completeness

Gas composition, animal methods, principal results and limitations checked in the open-access full text; generator flow was not reported.

A reported association, difference or mechanism is not automatically a clinical benefit. Null findings, outcome type, study design and precision all matter.

Interpretation limits

Cautions and applicability

Design and reporting cautions

Only 10 xenograft mice, preclinical model, no patient treatment experiment and several mechanistic analyses. The article did not use patient-derived or orthotopic xenografts and did not report gas flow.

Applies directly to

Colorectal-cancer cell lines and a mouse xenograft model; not people with colorectal cancer.

Preliminary appraisal framework

Not reported in this record.

Preliminary risk-of-bias status

Not reported in this record.

Appraisal rationale

Not reported in this record.

No single-study GRADE certainty rating is assigned. Certainty is assessed by important outcome across a complete eligible evidence set, not by attaching a final grade to one source.

Provenance

Sources and record status

Identifiers

PMID: 35528164 · DOI: 10.1155/2022/8024452

Publisher access

Open-access full text is available through PMC.

Extraction basis

Open-access PMC full text and PubMed bibliographic record.

Record revision

2026-08-10